| pubmed-article:10663432 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C0003402 | lld:lifeskim |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C0034693 | lld:lifeskim |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:10663432 | lifeskim:mentions | umls-concept:C1883709 | lld:lifeskim |
| pubmed-article:10663432 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10663432 | pubmed:dateCreated | 2000-3-10 | lld:pubmed |
| pubmed-article:10663432 | pubmed:abstractText | Investigators have postulated that neuroleptic medications may affect the motor system through the creation of free radicals. Also, structural brain changes related to oxidative damage may disrupt normal striatal function. | lld:pubmed |
| pubmed-article:10663432 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10663432 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10663432 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10663432 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:10663432 | pubmed:issn | 0033-3158 | lld:pubmed |
| pubmed-article:10663432 | pubmed:author | pubmed-author:LohrJ BJB | lld:pubmed |
| pubmed-article:10663432 | pubmed:author | pubmed-author:CaligiuriM... | lld:pubmed |
| pubmed-article:10663432 | pubmed:author | pubmed-author:ManleyM SMS | lld:pubmed |
| pubmed-article:10663432 | pubmed:author | pubmed-author:BrowningJ AJA | lld:pubmed |
| pubmed-article:10663432 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10663432 | pubmed:volume | 148 | lld:pubmed |
| pubmed-article:10663432 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10663432 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10663432 | pubmed:pagination | 171-9 | lld:pubmed |
| pubmed-article:10663432 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:meshHeading | pubmed-meshheading:10663432... | lld:pubmed |
| pubmed-article:10663432 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:10663432 | pubmed:articleTitle | Neuroleptic-induced striatal damage in rats: a study of antioxidant treatment using accelerometric and immunocytochemical methods. | lld:pubmed |
| pubmed-article:10663432 | pubmed:affiliation | VA San Diego Healthcare System and Department of Psychiatry, University of California, San Diego, California, USA. | lld:pubmed |
| pubmed-article:10663432 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10663432 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:10663432 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:10663432 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10663432 | lld:pubmed |
